サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709451

流動性止血剤の世界市場：製品種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Flowable Hemostats Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 322 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
流動性止血剤の世界市場：製品種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートのハイライト

流動性止血剤の市場規模は2024年に7億5,054万米ドルとなり、2025年から2032年にかけてCAGR 6.01％で拡大。

より迅速な塗布や生体適合性の向上など、止血技術の進歩がその有効性を高めています。さらに、低侵襲手術の需要が流動性止血剤の使用を後押ししています。北米と欧州は先進的な医療システムにより市場をリードしているが、アジア太平洋は急速な成長を遂げています。課題としては、高コストと規制上のハードルが挙げられます。しかし、医療への投資と技術革新の増加は、市場拡大の原動力となっています。

流動性止血剤の市場力学

世界の外科手術の増加による止血剤需要の増加

世界の外科手術件数の増加は、流動性止血剤市場の重要な促進要因です。Lancet誌に掲載された研究では、世界全体で毎年約2億3,400万件の大手術が行われていると推定されています。このような手術件数の多さは、手術中の出血を管理する効果的な止血剤の重要な必要性を裏付けています。

流動性止血剤は、適用が容易で出血を抑制する効果が高いことで知られており、外科手術のツールキットにおいて不可欠なツールになりつつあります。世界人口の高齢化と慢性疾患の蔓延に伴い、外科的介入の需要は増加し、高度な止血ソリューションの必要性がさらに高まると予想されます。

流動性止血剤市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約6.01％のCAGRで年間成長すると推定されます。

製品種類別では、ゼラチンベース止血剤が2024年に最大の市場シェアを示すと予測されています。

用途別では、心臓血管外科が2024年の主要用途でした。

エンドユーザー別では、2024年には病院が主要エンドユーザーでした。

地域別では、北米が2024年の売上高をリードしています。

流動性止血剤市場：セグメンテーション分析

流動性止血剤の世界市場は、製品種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

製品種類別に4つに分類されます：ゼラチンベース止血剤、コラーゲンベース止血剤、複合止血剤、トロンビンベース止血剤です。ゼラチンベースの止血剤は、その汎用性、有効性、様々な外科手術中の出血をコントロールする使いやすさから、流動性止血剤市場を独占しています。これらの止血剤は、血液を速やかに吸収し、凝固を促進する機械的バリアを形成することで機能します。心臓血管外科、整形外科、一般外科などで広く使用されており、市場の牽引役となっています。米国食品医薬品局（FDA）によると、ゼラチンベースの止血剤は、手術室で最も一般的に承認され使用されている止血剤のひとつです。生体適合性、適用のしやすさ、不規則な創傷面への有効性から外科医に好まれています。さらに、低侵襲手術や外傷症例の増加が需要をさらに押し上げています。製剤の改良や吸収速度の向上など、絶え間ない進歩がその性能を高め、市場リーダーとしての地位を確固たるものにしています。

市場は用途によって2つのカテゴリーに分けられます：心臓血管外科、整形外科、一般外科、脳神経外科、婦人科外科、泌尿器科外科、その他です。心臓血管外科は、効果的な出血コントロールを必要とする複雑な手技が多いことから、流動性止血剤市場を独占しています。米国疾病予防管理センター（CDC）によると、米国では年間約80万5,000件の心臓発作が発生しており、心臓手術の急増を牽引しています。流動性止血剤は、これらの手術において、デリケートで届きにくい部位の出血を管理し、合併症のリスクを軽減するために極めて重要です。外科医は、不規則な表面や活発な出血部位でも機能するこの止血剤を好んで使用しています。心臓病の有病率の増加、人口の高齢化、バイパス手術や弁置換術などの心臓手術の進歩が需要をさらに押し上げています。低侵襲的な心臓血管治療へのシフトは、迅速かつ効率的な止血ソリューションの使用を増加させ、心臓血管外科を主要なアプリケーションセグメントとして確固たるものにしています。

流動性止血剤市場：地域別分析

北米は、手術件数の多さと先進的な医療インフラによって、流動性止血剤市場で大きなシェアを占めています。米国疾病予防管理センター（CDC）によると、米国では年間5,000万件以上の外科手術が行われており、効果的な止血ソリューションに対する需要が高まっています。この地域では、FDAの承認が頻繁に得られるため、革新的な止血剤の導入が促進されています。心血管障害やがんなどの慢性疾患の蔓延が手術件数を増加させ、市場の成長をさらに後押ししています。さらに、外科的介入を受けやすい高齢者人口の増加が、高度な止血剤の需要に寄与しています。ジョンソン・エンド・ジョンソン、バクスター、メドトロニックなどの大手企業は、製品の有効性を高めるために研究開発に多額の投資を行っています。特に外来手術センターにおける外来手術や低侵襲手術の増加も需要を促進しています。全体として、旺盛な医療支出と技術の進歩により、北米は流動性止血剤の主要市場となっています。

米国は、手術件数の多さと先進医療施設によって、流動性止血剤市場で大きなシェアを占めています。CDCによると、米国では年間5,000万件以上の手術が行われており、効果的な止血ソリューションに対する需要が高まっています。ジョンソン・エンド・ジョンソン、バクスター、メドトロニックといった大手企業の存在は、継続的な技術革新と新製品の発売を通じて市場の成長に寄与しています。さらに、高齢化人口の増加や、心血管障害やがんなどの慢性疾患の有病率の上昇が、外科的介入を促進しています。FDAの頻繁な承認による強力な規制の枠組みが、先進的な止血製品の急速な普及を支えています。医療研究への資金拠出が増加し、医療支出も増加していることも、市場拡大に拍車をかけています。特に外来手術センターにおける外来患者や低侵襲手術の増加が、使いやすい止血剤の需要を押し上げています。さらに、事故による外傷が緊急処置における流動性止血剤の使用増加に寄与しています。全体として、米国は引き続き高い成長ポテンシャルを有する主要市場です。

流動性止血剤市場：競合情勢

流動性止血剤市場は、技術進歩、製品イノベーション、主要企業間の戦略的提携によって、競争が激しくなっています。各社は、有効性の向上、迅速な適用、優れた生体適合性を備えた止血ソリューションの導入に向けて研究開発に注力しています。FDA（米国食品医薬品局）の頻繁な承認と新製品の上市が市場の拡大を後押ししています。病院や手術センターとの合併・買収・提携は、市場での存在感を高めるための一般的な戦略です。ジョンソン・エンド・ジョンソン（Ethicon）、バクスターインターナショナル（Floseal Hemostatic Matrix）、ベクトン・ディッキンソン・アンド・カンパニー（BD）、メドトロニック、ファイザーなどの主要企業は、幅広い止血ソリューションで市場を独占しています。さらに、Stryker、Teleflex、CryoLife、CSL Behring、Hemostasis, LLC、Tissuemed Ltdなどの企業が、継続的なイノベーションを通じてポートフォリオを拡大しています。競合情勢は、低侵襲手術技術への投資や医療プロバイダーとの提携によってさらに形成されています。この激しい競争は、製品の性能、安全性、アクセシビリティの向上を促し、市場の持続的成長を確実なものにしています。

目次

第1章 流動性止血剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 流動性止血剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 流動性止血剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 流動性止血剤市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 流動性止血剤の市場情勢

  • 流動性止血剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 流動性止血剤市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • ゼラチンベース止血剤
    • コラーゲンベーの止血剤
    • 複合止血鉗子
    • トロンビンベース止血剤

第8章 流動性止血剤市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 心臓血管外科
    • 整形外科
    • 一般外科
    • 脳神経外科
    • 婦人科手術
    • 泌尿器科手術
    • その他

第9章 流動性止血剤市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • 外来手術センター（ASC）
    • 専門クリニック
    • 外傷センター

第10章 流動性止血剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：流動性止血剤業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Johnson &Johnson Services, Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company（BD）
    • Pfizer Inc.
    • Medtronic plc
    • Teleflex Incorporated
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • CSL Behring LLC
    • CryoLife, Inc.
    • Ethicon, Inc.
    • Mallinckrodt Pharmaceuticals
    • Z-Medica, LLC
    • Hemostasis, LLC
    • Tissuemed Ltd
    • Biocer Entwicklungs-GmbH

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4926

REPORT HIGHLIGHT

Flowable Hemostats Market size was valued at US$ 750.54 Million in 2024, expanding at a CAGR of 6.01% from 2025 to 2032.

The Flowable Hemostats Market focuses on products used to control bleeding during surgical procedures. Flowable hemostats are thick, gelatinous substances that combine a hemostatic agent with a carrier material, making them easy to apply to irregular wound surfaces. These hemostats work by accelerating the body's natural clotting process, helping to manage bleeding quickly and effectively. They are widely used in surgeries such as cardiovascular, orthopedic, and general procedures. The market is driven by the rising number of surgical procedures globally, an aging population, and increasing trauma cases.

Advancements in hemostatic technology, such as faster application and improved biocompatibility, are enhancing their effectiveness. Additionally, the demand for minimally invasive surgeries has boosted the use of flowable hemostats. North America and Europe currently lead the market due to advanced healthcare systems, while Asia-Pacific is experiencing rapid growth. Challenges include high costs and regulatory hurdles. However, increasing healthcare investments and innovations continue to drive market expansion.

Flowable Hemostats Market- Market Dynamics

Rising surgical procedures globally increasing demand for hemostatic solutions.

The increasing number of surgical procedures worldwide is a significant driver for the flowable hemostats market. A study published in The Lancet estimated that approximately 234 million major surgical procedures are performed globally each year. This high volume underscores the critical need for effective hemostatic agents to manage bleeding during surgeries.

Flowable hemostats, known for their ease of application and efficacy in controlling bleeding, are becoming essential tools in the surgical toolkit. As the global population ages and the prevalence of chronic diseases rises, the demand for surgical interventions is expected to increase, further propelling the need for advanced hemostatic solutions.

Flowable Hemostats Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2025-2032)

Based on product type segmentation, Gelatin-based hemostats was predicted to show maximum market share in the year 2024

Based on application segmentation, Cardiovascular surgery was the leading application in 2024

Based on End-user segmentation, Hospitals was the leading end-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Flowable Hemostats Market- Segmentation Analysis:

The Global Flowable Hemostats Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into Four categories based on product type: Gelatin-based Hemostats, Collagen-based Hemostats, Combination Hemostats, and Thrombin-based Hemostats. Gelatin-based hemostats dominate the flowable hemostats market due to their versatility, effectiveness, and ease of use in controlling bleeding during various surgical procedures. These hemostats work by absorbing blood rapidly and creating a mechanical barrier to promote clotting. Their widespread use in cardiovascular, orthopedic, and general surgeries drives their market leadership. According to the U.S. Food and Drug Administration (FDA), gelatin-based hemostats are among the most commonly approved and utilized hemostatic agents in operating rooms. Surgeons prefer them for their biocompatibility, ease of application, and effectiveness on irregular wound surfaces. Additionally, the rising number of minimally invasive surgeries and trauma cases has further fueled their demand. Continuous advancements, such as improved formulations and faster absorption rates, are enhancing their performance, solidifying their position as the market leader.

The market is divided into two categories based on application: Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Gynecological Surgery, Urology Surgery, Other. Cardiovascular surgery dominates the flowable hemostats market due to the high volume of complex procedures requiring effective bleeding control. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attacks occur annually in the U.S., driving a surge in cardiac surgeries. Flowable hemostats are crucial in these surgeries to manage bleeding in delicate and hard-to-reach areas, reducing the risk of complications. Surgeons prefer them for their ability to work on irregular surfaces and in active bleeding sites. The increasing prevalence of heart diseases, aging populations, and advancements in cardiac procedures, such as bypass surgeries and valve replacements, further boost demand. The shift towards minimally invasive cardiovascular interventions has increased the use of quick and efficient hemostatic solutions, solidifying cardiovascular surgery as the leading application segment.

Flowable Hemostats Market- Geographical Insights

North America holds a major share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), over 50 million surgical procedures are performed annually in the U.S., increasing the demand for effective hemostatic solutions. The region benefits from frequent FDA approvals, which facilitate the introduction of innovative hemostatic products. The growing prevalence of chronic diseases, such as cardiovascular disorders and cancer, has increased the number of surgeries, further driving market growth. Additionally, a rising elderly population, which is more susceptible to surgical interventions, contributes to the demand for advanced hemostats. Major players like Johnson & Johnson, Baxter, and Medtronic are heavily investing in research and development to enhance product efficacy. The increase in outpatient procedures and minimally invasive surgeries, especially in ambulatory surgical centers, has also fueled demand. Overall, strong healthcare spending and technological advancements make North America a key market for flowable hemostats.

The United States holds a significant share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare facilities. According to the CDC, over 50 million surgeries are performed annually in the U.S., increasing the demand for effective bleeding control solutions. The presence of major players such as Johnson & Johnson, Baxter, and Medtronic contributes to market growth through continuous innovation and new product launches. Additionally, a growing aging population and rising prevalence of chronic diseases, such as cardiovascular disorders and cancer, are driving surgical interventions. The country's strong regulatory framework, with frequent FDA approvals, supports the rapid adoption of advanced hemostatic products. Increased funding for healthcare research and high healthcare expenditure further fuel market expansion. The rise in outpatient and minimally invasive surgeries, particularly in ambulatory surgical centers, has boosted demand for easy-to-use hemostats. Additionally, trauma cases from accidents contribute to increased usage of flowable hemostats in emergency procedures. Overall, the U.S. remains a key market with strong growth potential.

Flowable Hemostats Market- Competitive Landscape:

The flowable hemostats market is highly competitive, driven by technological advancements, product innovations, and strategic collaborations among key players. Companies are focusing on research and development to introduce hemostatic solutions with improved efficacy, faster application, and better biocompatibility. Frequent FDA approvals and new product launches are enhancing market expansion. Mergers, acquisitions, and partnerships with hospitals and surgical centers are common strategies to strengthen market presence. Leading players such as Johnson & Johnson (Ethicon), Baxter International (Floseal Hemostatic Matrix), Becton, Dickinson and Company (BD), Medtronic, and Pfizer dominate the market with a broad range of hemostatic solutions. Additionally, companies like Stryker, Teleflex, CryoLife, CSL Behring, Hemostasis, LLC, and Tissuemed Ltd are expanding their portfolios through continuous innovation. The competitive landscape is further shaped by investments in minimally invasive surgical technologies and collaborations with healthcare providers. This intense competition is driving improvements in product performance, safety, and accessibility, ensuring sustained market growth.

Recent Developments:

In April 2023, Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, including the launch of Floseal + Recothrom flowable hemostat. This helped the company to expand its product offerings and increase the reach of its product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLOWABLE HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Pfizer Inc.
  • Medtronic plc
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • CSL Behring LLC
  • CryoLife, Inc.
  • Ethicon, Inc.
  • Mallinckrodt Pharmaceuticals
  • Z-Medica, LLC
  • Hemostasis, LLC
  • Tissuemed Ltd
  • Biocer Entwicklungs-GmbH

GLOBAL FLOWABLE HEMOSTATS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Combination Hemostats
  • Thrombin-based Hemostats

GLOBAL FLOWABLE HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Surgery
  • Orthopedic Surgery
  • General Surgery
  • Neurosurgery
  • Gynecological Surgery
  • Urology Surgery
  • Other

GLOBAL FLOWABLE HEMOSTATS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Trauma Centers

GLOBAL FLOWABLE HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Flowable Hemostats Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Flowable Hemostats Market Snippet by Product Type
    • 2.1.2. Flowable Hemostats Market Snippet by Application
    • 2.1.3. Flowable Hemostats Market Snippet by End-user
    • 2.1.4. Flowable Hemostats Market Snippet by Country
    • 2.1.5. Flowable Hemostats Market Snippet by Region
  • 2.2. Competitive Insights

3. Flowable Hemostats Key Market Trends

  • 3.1. Flowable Hemostats Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Flowable Hemostats Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Flowable Hemostats Market Opportunities
  • 3.4. Flowable Hemostats Market Future Trends

4. Flowable Hemostats Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Flowable Hemostats Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Flowable Hemostats Market Landscape

  • 6.1. Flowable Hemostats Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Flowable Hemostats Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Gelatin-based Hemostats
    • 7.1.3. Collagen-based Hemostats
    • 7.1.4. Combination Hemostats
    • 7.1.5. Thrombin-based Hemostats

8. Flowable Hemostats Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular Surgery
    • 8.1.3. Orthopedic Surgery
    • 8.1.4. General Surgery
    • 8.1.5. Neurosurgery
    • 8.1.6. Gynecological Surgery
    • 8.1.7. Urology Surgery
    • 8.1.8. Other

9. Flowable Hemostats Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics
    • 9.1.5. Trauma Centers

10. Flowable Hemostats Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Flowable Hemostats Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Flowable Hemostats Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Flowable Hemostats Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Flowable Hemostats Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Flowable Hemostats Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Flowable Hemostats Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Baxter International Inc.
    • 11.2.3. Becton, Dickinson and Company (BD)
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Medtronic plc
    • 11.2.6. Teleflex Incorporated
    • 11.2.7. Integra LifeSciences Holdings Corporation
    • 11.2.8. Stryker Corporation
    • 11.2.9. CSL Behring LLC
    • 11.2.10. CryoLife, Inc.
    • 11.2.11. Ethicon, Inc.
    • 11.2.12. Mallinckrodt Pharmaceuticals
    • 11.2.13. Z-Medica, LLC
    • 11.2.14. Hemostasis, LLC
    • 11.2.15. Tissuemed Ltd
    • 11.2.16. Biocer Entwicklungs-GmbH

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us